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Abstract
Objectives—Farmers may be at increased risk for adverse respiratory outcomes compared with 
the general population due to their regular exposures to dusts, animals and chemicals. However, 
early life farm exposures to microbial agents may result in reduced risk. Understanding respiratory 
disease risk among farmers and identifying differences between farmers and other populations 
may lead to better understanding of the contribution of environmental exposures to respiratory 
disease risk in the general population.
Methods—We compared the prevalence of self-reported respiratory outcomes in 43548 
participants from the Agricultural Health Study (AHS), a prospective cohort of farmers and their 
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spouses from Iowa and North Carolina, with data from adult participants in the National Health 
and Nutrition Examination Survey (NHANES) over the same period (2005–2010).
Results—AHS participants had lower prevalences of respiratory diseases (asthma, adult-onset 
asthma, chronic bronchitis and emphysema), but higher prevalences of current respiratory 
symptoms (wheeze, cough and phlegm) even after controlling for smoking, body mass index and 
population characteristics. The overall prevalence of asthma in the AHS (7.2%, 95% CI 6.9 to 7.4) 
was 52% of that in NHANES (13.8%, 95% CI 13.3 to 14.3), although the prevalence of adult-
onset asthma among men did not differ (3.6% for AHS, 3.7% for NHANES). Conversely, many 
respiratory symptoms were more common in the AHS than NHANES, particularly among men.
Conclusions—These findings suggest that farmers and their spouses have lower risk for adult-
onset respiratory diseases compared with the general population, and potentially higher respiratory 
irritation as evidenced by increased respiratory symptoms.
INTRODUCTION
Farmers have a complex set of occupational and lifestyle exposures that may influence their 
respiratory health in both positive and negative ways. Since the 1500s, farmers have been 
identified as an occupational group at higher risk of respiratory disease than many other 
occupations due to their exposures to hays, grains and animals.1 However, recent evidence 
suggests that some farmers may have reduced risk of allergy and asthma as a result of early 
life2 and continued farm exposures.3 Farmers tend to have lower rates of smoking and 
higher levels of physical activity than the general population,4 tendencies that should also 
reduce respiratory risk. However, their exposures to inflammatory microbial agents from 
animals, hays and grains may contribute to chronic obstructive disease later in life.5 Many of 
the exposures potentially linked to respiratory disease in farmers are also important for the 
general population. Understanding risks among farmers and how these differ from the 
population at large may shed light on environmental contributors to respiratory disease in 
the population as a whole.
Evaluating how farmers compare with the general population is challenging. Few large 
population-based studies collect complete data on respiratory history. In Europe, respiratory 
symptoms among crop and animal farmers have been compared with population-based data 
from the European Community Respiratory Health Survey (ECRHS) for individuals 20–44 
years;67 similar comparisons have not been done in the USA. The present manuscript 
compares the respiratory health of a US farming population with that of the general 
population of the USA. Our data on a farming population come from The Agricultural 
Health Study (AHS) which is a cohort of farmers and their spouses in Iowa (IA) and North 
Carolina (NC) who have been followed since 1993. Our data on the general population come 
from the National Health and Nutrition Examination Survey (NHANES). Lifetime 
respiratory disease history along with current symptom information was collected in both 
studies from 2005 to 2010.
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The AHS is a prospective cohort including 52 394 licensed private pesticide applicators 
(farmers) and 32 345 of their spouses from IA and NC enrolled in 1993–1997 as well as 
4916 commercial applicators from IA (phase I). Licensed applicators and those newly 
seeking licenses were recruited at pesticide licensing sites. Approximately 82% of licensed 
pesticide applicators in both states enrolled. At enrolment, private applicators were given a 
second take-home questionnaire for themselves as well as an enrolment questionnaire for 
their spouse. Approximately 44% of applicators completed the take-home questionnaire and 
the spouses of 75% of married applicators enrolled. Since enrolment, private applicators and 
their spouses have completed up to two follow-up telephone interviews, approximately 5 
years apart; commercial applicators only received the first follow-up interview. Respiratory 
disease information was collected during the second follow-up phone interview (phase III). 
The phase III follow-up interview was conducted from November 2005 to February 2010. 
Individuals were eligible for the phase III interview if they were a private applicator or a 
spouse, were alive, had not refused future contact, were able to do a phone interview and, 
most importantly, had participated in some AHS activity (ie, take-home questionnaire, 
spouse enrolled, first follow-up interview) in addition to the enrolment questionnaire (figure 
1). This decision was made to minimise the expense of trying to contact individuals for 
phase III who appeared to have little interest in additional AHS participation. After some 
additional administrative exclusions (eg, people who participated in earlier pilot interviews), 
there were 70 175 phase III eligible AHS participants. A total of 44 130 individuals (24 171 
applicators, 19 959 spouses) completed the phase III interview with an overall response rate 
of 63% of those eligible. Response rates were slightly higher for spouses (66%) than for 
applicators (60%). The majority of the non-participants were those not reachable by phone 
(59%). This analysis focuses on the 43 548 AHS participants who completed the phase III 
questionnaire and provided information on respiratory outcomes, as they represent the 
largest sample of the AHS with data on respiratory health.
Respiratory outcome information
At enrolment, all participants completed questionnaires on demographic characteristics, 
smoking history, medical history and agricultural activities. This information was collected 
over the two instruments (enrolment and take-home questionnaires) for applicators, but only 
one (the spouse enrolment questionnaire) for spouses. Information on respiratory outcomes 
was collected from applicators on the take-home questionnaire and from spouses on their 
enrolment questionnaire. The enrolment questionnaires for applicators included information 
on current respiratory symptoms as well as respiratory disease history while spouses were 
asked only about respiratory diseases. The phase III follow-up interview included 
respiratory health outcomes and all participants were asked for the same information (http://
aghealth.nih.gov/background/questionnaires.html).
NHANES
We used data from the NHANES 2005–2010 surveys (http://www.cdc.gov/nchs/
nhanes.htm) to estimate the prevalence and incidence of respiratory outcomes in the US 
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population. The NHANES is a population-based survey of the US non-institutionalised 
population designed to assess the health and nutritional status of adults and children. It 
collects detailed medical history, including respiratory disease history, from approximately 
5000 people each year. For comparison with the AHS cohort, we used the data for adults 20 
years and older. The NHANES is aggregated to represent the USA as a whole; it does not 
provide state-specific data.
Outcome definitions
From the AHS phase III interview, we had detailed information on respiratory symptoms 
(wheeze, cough, phlegm and shortness of breath) and respiratory diseases (asthma, chronic 
bronchitis, chronic obstructive pulmonary disease (COPD), emphysema and farmer’s lung). 
We created variables from the AHS data that were similar to the questionnaire information 
collected in NHANES. In both the AHS and NHANES questionnaires, if participants 
reported a respiratory disease, they were asked to provide the age at diagnosis. We were 
unable to assess differences in allergic conditions because questions about allergy differed 
considerably between AHS and NHANES questionnaires. NHANES did not collect 
information on COPD or farmer’s lung and did not collect all symptom information (cough, 
phlegm and shortness of breath) for participants younger than 40. For completeness, we 
present all data on all respiratory outcomes collected in the AHS.
We defined the respiratory outcomes as follows:
Respiratory diseases:
• Asthma=ever diagnosed with asthma
• Childhood asthma=asthma diagnosed before age 20
• Adult-onset asthma=asthma diagnosed age 20 or older
• Farmer’s lung=ever diagnosed with farmer’s lung disease
• Emphysema=ever diagnosed with emphysema
• Chronic bronchitis=ever diagnosed with chronic bronchitis
• COPD=ever diagnosed with COPD.
Symptoms:
• Cough=usually cough either at waking or during the rest of the day
• Phlegm=usually produce phlegm either at waking or during the rest of the day
• Chronic cough and phlegm=cough and phlegm for 2 or more years
• Wheeze=any episode of wheeze in the past 12 months
• Shortness of breath=shortness of breath when hurrying on level ground, walking up 
a hill or fiight of stairs.
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We calculated the population prevalence and 95% CI for each respiratory disease and 
symptom within the AHS and NHANES populations. We also calculated the incidence rate 
and 95% CI for newly diagnosed respiratory diseases. Using the age at diagnosis 
information at the most recent interview, we defined incident disease as diagnoses occurring 
at an age greater than or equal to the age at enrolment for AHS or within the past 12 years 
for NHANES. We assumed a 12-year follow-up interval for NHANES for incident 
outcomes, such that diseases diagnosed within 12 years of NHANES participation were 
considered incident for comparison with the AHS data, as the median time from AHS 
enrolment to phase III interview was 12.0 years (range 8.1–16.1 years). Age at diagnosis 
was available for the majority of respiratory disease cases in the AHS with fewer than 5% 
failing to report an age at diagnosis. Additionally, for the AHS, we used previously reported 
information on respiratory outcomes (available for 75% of participants; 55% of applicators 
and 100% of spouses) to correct for misreports of incident disease by excluding those who 
reported the outcome at enrolment (7% of emphysema, 13% of asthma, 19% of farmer’s 
lung and 20% of incident chronic bronchitis cases). Data for making such corrections were 
unavailable for the NHANES sample. All estimates from NHANES were weighted using the 
supplied survey weights to yield nationally representative data. The weights take into 
account factors such as the complex survey design, survey non-response and 
poststratification. To compare the prevalence and incidence of respiratory outcomes between 
AHS and NHANES, we used a Z-test to compare the two proportions. To account for 
differences in population characteristics between AHS and NHANES, we adjusted for age 
(categories), race (white, non-white), gender, smoking (ever, never) and body mass index 
(BMI; <25, 25–30, >30) via logistic regression. To accommodate the sampling design of 
NHANES, we fit models with PROC SURVEYLOGISTIC that specified sampling stratum, 
primary sampling unit and sampling weight. The stratum variable contained the NHANES 
stratum (SDMVSTRA) for NHANES subjects and state for AHS subjects. The sampling-
unit variable contained the NHANES sampling unit (SDMVSPSU) for NHANES subjects 
and an individual identifier for each AHS participant. For NHANES, we used NHANES 
sampling weights rescaled to sum to the total number of NHANES participants; for AHS, 
each participant had a sampling weight of 1. All analyses were conducted using SAS V.9.3.
RESULTS
A total of 44 130 AHS participants completed the phase III interview, and 43 548 provided 
information on respiratory outcomes. At that time, ages ranged from 27 to 97 years 
(mean=59.4, SD=11.6). The AHS is primarily white (98%) and 66% from IA. The pesticide 
applicators are mainly men, while the spouses are primarily women. A majority of AHS 
participants grew up on farms, 62% of women and 92% of men. At the time of the 2005–
2010 follow-up interview, 73% of men and 30% of women were still engaged in farming 
(table 1). Farmers in the AHS engage in a wide range of agricultural activities involving 
both crops and animals (see online supplementary table). The NHANES 2005–2010 sample 
consisted of 17 132 adult Americans with results weighted to represent the US adult, non-
institutionalised population. The average age was 46.7 years, ranging from 20 to 85 years. In 
contrast to the AHS, the NHANES population is 30% non-white. Compared with NHANES, 
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a greater proportion of AHS participants were lifetime never smokers (68% never smokers 
in AHS vs 53% in NHANES) and are less likely to currently smoke (7% vs 22%, table 1). In 
both groups, 85% reported visiting a doctor within the past year, though the frequency was 
lower among NHANES men (78%) than NHANES women (91%). A greater proportion of 
individuals in the AHS reported excellent health status (19% vs 10% for NHANES), but the 
per cent of individuals reporting poor health was similar in both groups (3% for AHS, 4% 
for NHANES).
Asthma was the most common respiratory disease and emphysema was the least common in 
both populations (table 2). All respiratory diseases had significantly lower prevalence in the 
AHS cohort than in NHANES; however, symptom prevalence was higher in the AHS. The 
largest difference in disease prevalence was for asthma, with an estimated prevalence of 
7.2% (95% CI 6.9 to 7.4) among AHS participants, approximately half the prevalence 
observed among NHANES participants (13.8%, 95% CI 13.3 to 14.3). While still lower in 
the AHS, the difference in the prevalence of adult-onset asthma was not as large (adjusted 
prevalence ratio (PR)=0.65 (95% CI 0.57 to 0.74)). Some current respiratory symptoms 
(wheeze, cough and phlegm) were more common in AHS than NHANES participants while 
respiratory symptoms potentially more indicative of poorer health (eg, shortness of breath 
and chronic cough and phlegm) were higher among NHANES participants. The prevalence 
of wheeze in the AHS (20.1%, 95% CI 19.7 to 20.5) was higher than that for NHANES 
(14.1%, 95% CI 13.5 to 14.6). The PR for wheeze was 1.66 (95% CI 1.51 to 1.82) when 
adjusted for differences between NHANES and AHS. For those 40 years and older, reports 
of cough and phlegm were 14%–16% higher in the AHS than in NHANES.
Differences in disease and symptoms varied by gender and smoking. Among men, the 
prevalence of adult-onset asthma was no longer statistically different between the AHS and 
NHANES (figure 2A). In general, women were more likely to report asthma and chronic 
bronchitis than men, but women in the AHS had lower prevalences of all respiratory 
diseases than women in NHANES. For respiratory symptoms among participants 40 and 
older (figure 2B), wheeze was more common among men in the AHS (24%, 95% CI 23% to 
24%) than among men in NHANES (15%, 95% CI 14% to 16%); this relationship was seen 
in both smokers and non-smokers. Cough and phlegm were each more common among men 
in the AHS than men in NHANES; yet women in the AHS had similar (cough) or lower 
prevalence (phlegm) compared with women in NHANES. Among non-smokers, cough and 
phlegm were more prevalent in the AHS than in NHANES; but, among smokers, cough and 
phlegm each showed similar prevalence between the two populations.
Among non-smokers, AHS participants had lower prevalence of respiratory disease than 
NHANES participants except for emphysema which had higher prevalence among the AHS 
participants (0.3%, 95% CI 0.3 to 0.4 vs 0.2%, 95% CI 0.1 to 0.3, p=0.03). In analyses 
restricted to people over 40, this difference was no longer statistically significant (data not 
shown). All respiratory symptoms, including chronic cough and phlegm, were more 
common in AHS non-smokers than NHANES non-smokers. Smokers were more likely to 
report respiratory disease than non-smokers both in the AHS and NHANES (figure 2A,B); 
however, among those with respiratory disease, the AHS has a higher proportion of non-
smokers (see online supplementary figure).
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The estimated 12-year incidence of all respiratory diseases was greater among NHANES 
than AHS participants (table 3). The incidence rate of asthma in the AHS was 2.1/1000 
person-years (PY) compared with 4.0/1000 PY in NHANES. The incidence rate of chronic 
bronchitis was also lower in the AHS (1.2/1000 vs 2.1/1000 PY). Similarly reduced rates 
were seen within the smoking and gender strata.
DISCUSSION
Participants in the AHS had higher prevalence of self-reported respiratory symptoms than 
the general population despite lower rates of respiratory disease diagnoses and smoking and 
presumably more physically demanding work than the general population. Respiratory 
symptoms may be indicative of respiratory disease or may occur in response to irritants or 
other stressors. Farmers are exposed to many potential respiratory irritants including 
allergens, diesel exhaust, pesticides, hays, grains and dusts. How these exposures influence 
long-term respiratory health is an area of active research.1 Diesel exhaust enhances the 
allergenicity of allergens;8 thus, coexposures on farms may result in increased airway 
symptoms. Endotoxins and glucans from bacteria and molds are agents that, in addition to 
irritating airways, can also contribute to airway inflammation.69–12 These inflammatory 
agents are believed to contribute to COPD in non-smokers in microbial rich environments, 
such as farms or developing countries where biomass fuels are used and many other 
environmental and infectious agents are present.1213 Although specific pesticides have been 
shown to increase allergic airway responsiveness in animals and humans,14–17 growing up 
on a farm reduces an individual’s lifetime risk of allergy and asthma.231819
Current symptoms of wheeze, cough and phlegm were higher among AHS participants, 
whereas symptoms of shortness of breath and chronic cough and phlegm were higher in the 
general population even after controlling for differences in age, race, gender, smoking and 
BMI. Shortness of breath as well as chronic cough and phlegm are indicative of poorer 
health and, thus, possibly inversely associated with the ability to farm.20 Growing up on a 
farm protects against allergy and asthma, and probably results in sensitive individuals 
removing themselves from farms, such that those with reactive airways may choose not to 
become or remain farmers.21 This hypothesis is supported by the lower prevalence of ever 
asthma among those in the AHS, but a more similar prevalence for adult-onset asthma 
among men in the AHS and NHANES. For other adult-onset respiratory diseases, namely, 
chronic bronchitis and emphysema, we see evidence of a healthy worker effect as the 
prevalence and incidence of these diseases was lower among AHS than NHANES 
participants. In a recent US survey, the prevalence of COPD was much higher among those 
who were unable to work compared with those who were employed.22 Radon and colleagues 
have demonstrated a healthy worker selection bias in cohort studies of chronic bronchitis, as 
those with symptoms tend to remove themselves from exposure.20
Lower smoking rates should reduce risk of obstructive airway disease and symptoms and, 
yet, in our population, we see somewhat conflicting information. The individual symptoms 
of current cough and phlegm were higher among AHS participants, even among non-
smokers. However, the overall prevalence of chronic cough and phlegm was higher in 
NHANES than the AHS, but when restricted to lifetime never smokers, individuals in the 
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AHS had higher prevalence of chronic cough and phlegm. Among farmers, working with 
livestock has been associated with chronic bronchitis in both smokers and non-smokers.1011 
Approximately 15% of COPD is attributable to occupation.23 Among non-smokers, 
however, occupation probably plays a larger role, particularly in a population such as 
farmers where exposures may occur over a lifetime. Approximately 31% of COPD was 
attributable to work among never smokers based on the NHANES 1988–1994 data.24
The AHS represents the largest sample of farm women studied for respiratory conditions. As 
in other studies, women were at higher risk of adult-onset respiratory diseases than men.25 
Like the men in the AHS, women in the AHS had a lower prevalence of respiratory disease 
than women in NHANES and, with the exception of wheeze, had a lower prevalence of 
symptoms as well. Only 22% of the women in the AHS had ever smoked, compared with 
40% in NHANES. This lower prevalence of smoking coupled with the lower risk of asthma 
and allergy potentially due to growing up on the farm and performing farm work likely 
explains the reduced risk among farm women compared with the general population.
The prevalence of respiratory disease and symptoms among farmers has been evaluated 
around the world in studies large and small using varying outcome definitions. To our 
knowledge, the AHS with 44 130 participants providing detailed respiratory information is 
the largest prospective study of respiratory disease incidence and prevalence among farmers 
and their spouses to date. Wheeze has been reported in a number of other studies of farmers 
with prevalence ranging from 11.7% for male Swedish farmers26 to 18% for New Zealand 
farmers3 and New York farmers and farm residents.27 Our overall estimate for wheeze of 
20.1% is at the high end of the estimates, but is consistent with the wheeze prevalence at 
enrolment for private applicators (referred to here as farmers, 19%)28 and commercial 
pesticide applicators (21%).29 The prevalence of asthma among farmers in previous studies 
varies from 2.8% among European animal farmers7 to 14.8% for New Zealand farmers;3 our 
estimated prevalence of 7.2% is consistent with estimates from New York dairy farmers 
(7.7%)30 and Swedish farmers (8.9%).31 Our estimated prevalence for chronic bronchitis of 
3.5% was lower than most other previous studies of farmers, but chronic bronchitis is a more 
difficult disease to assess through self-report, and differences in diagnostic practices as well 
as agricultural exposures may contribute to these differences.
Other investigators have compared groups of farmers to population-based estimates of 
respiratory symptoms and disease. In Iceland, Sigurdarson and colleagues saw no significant 
differences in respiratory disease and symptoms among 1107 farmers compared with 
national estimates.32 Similar to our findings, Icelandic farmers had a lower prevalence of 
lifetime asthma with no difference in current asthma. Among Norwegian farmers, both 
atopic and non-atopic asthma were less prevalent than in the general population.33 In a 
larger study focusing on farmers from four European countries (Denmark, Germany, 
Switzerland and Spain), Radon et al7 and Monso et al6 compared respiratory health data 
from more than 6000 animal farmers and almost 4800 crop farmers with data from the 
general population ECRHS conducted in these regions; the same instrument was used to 
collect respiratory data in all participants. Among animal farmers, the prevalence of the 
respiratory symptoms (wheeze, shortness of breath and asthma) was lower than the 
comparison population of ECRHS participants; only phlegm production was more common 
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among farmers and prevalence of this symptom remained elevated when limited to younger 
farmers (<45 years).7 Among crop farmers, the prevalence of respiratory symptoms was 
similar to the general European population.6 While the European studies compared 
respiratory disease experience for different types of farming, animal and crop, we did not 
analyse our data by specific commodity groups, as many farmers in our cohort produce both 
crops and animals over the course of their lifetimes. Additionally, we only have data for 
production at three points in time; thus, it would be difficult to correctly classify an 
individual with respect to lifetime farming activities.
Ours is the first large study of farmers to report asthma incidence rates. In a review of 
exposure and respiratory health of farmers, Omland5 noted the lack of longitudinal studies 
of asthma in farming populations. Previous studies have estimated the incidence rates for 
asthma among farmers from occupational codes on questionnaires or death certificates, 
resulting in heterogeneity in classifying farmers.534 In a 12-year follow-up study of 418 
Swedish farmers, Rask-Andersen31 reported that the prevalence of doctor-diagnosed asthma 
increased from 2% to 8.9% from 1982 to 1994, suggesting an estimated incident rate of 
5.8/1000 PY, much higher than our estimate for the AHS (2.1/1000 PY) or NHANES 
(4.0/1000PY).
Like other large surveys, we relied on self-reported respiratory disease and symptom history 
to assess disease incidence and prevalence. Some diseases, such as asthma, are more 
accurately reported than other diseases, such as chronic bronchitis, but it is unlikely that the 
reporting errors of these diseases differ between the NHANES and AHS populations. We do 
not anticipate diagnostic differences between smokers and non-smokers because the 
frequency of pulmonary function testing and medication use for COPD did not differ by 
smoking status in another US population-based sample.22 We used age at diagnosis to 
estimate disease incidence, a measure that has been used by other researchers;35 in addition, 
we were able to correct incidence estimates by removing prevalent disease reported at 
enrolment. The impact of this correction on incidence rates was small, as the actual number 
of cases affected was low and the number of PY was large; thus, this correction was too 
small to explain the differences in incidence rates between the AHS and NHANES. Among 
Finnish adults, the sensitivity of asthma incidence (63%) was less than for asthma 
prevalence (91%) when disease information was collected 4 years apart.36 With a longer 
follow-up period and the use of enrolment information to correct misreported information, it 
is likely that our sensitivity for incident disease is higher.
We compared the respiratory health in the AHS cohort with a nationally representative 
sample collected over the same calendar period. The advantage in using nationally 
representative data is that it allows comparison with a standard set of data without restricting 
it to unique subgroups (eg, older white adults) that no longer represent the whole. While the 
AHS population was older and less racially diverse than NHANES, these factors did not 
explain the differences in prevalence observed between the two groups. It is unlikely that 
access to medical care influenced these findings as 85% of participants in both the AHS and 
NHANES had visited a doctor within the past year. Another advantage is that the data from 
the AHS and NHANES were collected over the same calendar years. Asthma rates in the 
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USA have been increasing over time,37 and diagnostic practices change over time, and so 
use of contemporaneous information is critical for valid comparisons.
The AHS is a cohort of farm owners and operators and their spouses and does not include 
seasonal, temporary or other agricultural workers. Cohort members engage in a wide range 
of agricultural activities representative of Midwestern and Southern agriculture in the USA. 
In this sample, we observed higher prevalence of respiratory symptoms, yet lower 
prevalence and incidence of respiratory disease compared with a representative US sample. 
While respiratory disease prevalence was lower than the general population, the proportion 
of those with respiratory disease who were non-smokers was higher among farmers. Even 
though farmers have lower rates of disease, understanding the exposures that contribute to 
respiratory symptoms and disease among non-smoking farmers should be explored in detail.
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What this paper adds
• Farmers have different respiratory exposures and different respiratory risks than 
the general population.
• Few studies have been able to compare farmers with general population data.
• In the largest study of farmers to date, this study shows that US farmers and 
their spouses have lower rates of respiratory disease than the US population, but 
higher rates of respiratory symptoms, perhaps due to occupational exposure to 
respiratory irritants.
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Agricultural Health Study (AHS) sample selection criteria and response rates.
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(A) Prevalence of respiratory disease in the Agricultural Health Study (AHS) and NHANES, 
National Health and Nutrition Examination Survey (NHANES) stratified by gender and by 
smoking status. (B) Prevalence of respiratory symptoms in the AHS and NHANES stratified 
by gender and by smoking status for those 40 years and older.
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